Phase III trial also demonstrated a statistically significant reduction (14%) in hospitalization for any cause, bringing potential relief for patients and reducing burden on healthcare systems
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
MonoFerric, iron isomaltoside 1000 solution for injection/infusion, is a rapid, single dose IV iron developed to reduce the number of infusions
Therapy recently approved in Canada under the brand name KORSUVA
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
Subscribe To Our Newsletter & Stay Updated
